(Q44318951)

1 December 2017

title

Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis (English)

1 reference

1 December 2017

1 reference

Silverman S Jr

1

1 reference

1 December 2017

Gallo JW

2

1 reference

1 December 2017

McKnight ML

3

1 reference

1 December 2017

Mayer P

4

1 reference

1 December 2017

deSanz S

5

1 reference

1 December 2017

Tan MM

6

1 reference

1 December 2017

publication date

1 October 1996

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

1 December 2017

published in

1 reference

1 December 2017

volume

82

1 reference

1 December 2017

issue

4

1 reference

1 December 2017

page(s)

402-407

1 reference

Oral findings in patients with acquired immunodeficiency syndrome

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Oral mycoses in HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Oral carriage of Candida in healthy and HIV-seropositive persons

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

VA oral HIV surveillance program: understanding the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Oral mucosal lesions: association with the presence of antibodies to the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Oral manifestations of HIV infection in homosexual men and intravenous drug users. Study design and relationship of epidemiologic, clinical, and immunologic parameters to oral lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Host factors associated with HIV-related oral candidiasis. A review

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Oral candidiasis. History, classification, and clinical presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Oral azole drugs as systemic antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Treatment of oral candidiasis in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

A review of oral fungal infections and appropriate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Candida species and Candida albicans morphotypes in erythematous candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Immunologic aspects of oral candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Oral candidiasis: pathogenesis and host defense

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Relationship of oral disease to the presence of cytomegalovirus DNA in the saliva of AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Oral Candida: clearance, colonization, or candidiasis?

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

Relationship between salivary flow rates and Candida albicans counts

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2896%2980304-0

7 January 2021

10.1016/S1079-2104(96)80304-0

Identifiers

DOI

1 reference

1 December 2017

1 reference